Unfortunately, any woman can get cervical cancer (РШМ) since this type of cancer is caused by a very common sexually transmitted virus. This is a specific type of virus - high risk human papillomavirus (HPV) i.e«Oncogenic type». There are several such viruses, but the most malignant ones are IDPs 16, 18, 31, 33, and 45. The peak of cervical cancer diseases reaches the age of 25-45 years. Every day in Ukraine, 6 women die from this disease.
Human papillomavirus- transmission methods
What do we know about human papillomavirus? The virus enters the human body mainly through sexual contact, through the mucous membranes of the genital organs, infects the basal cells, causing them to divide uncontrollably. It is this division of the altered cells that causes the appearance of warts or genital warts.
The incubation period of HPV reaches 2-3 months. Most often, HPV is asymptomatic in the blood of a carrier if the immune defense is sufficient to prevent its excessive activation. As soon as immunity decreases (under the influence of stress, hypothermia or other factors), human papillomavirus infection begins to manifest itself.
What to do if a person is already infected with papillomavirus infection?
It is necessary to contact specialists. After a thorough examination, doctors will prescribe an adequate, effective treatment. It can be either local creams or a variety of methods for removing genital warts (cryodestruction, diathermocoagulation), depending on the degree of infection.
Unfortunately, the removal of genital warts does not mean the expulsion of papillomavirus from the human body, although it eliminates the clinical picture of this ailment. In this regard, doctors recommend vaccinating.
Vaccination against HPV
Vaccination creates a barrier to the penetration of the virus into healthy cells of the cervix, in addition, it provides lasting protection against 5 types of HPV (strains 16, 18, 31, 33, 45).
If an infected person has only one type of virus, then after vaccination it will be protected from others.
In the Bogoliuby Medical Center, vaccinations are done with a vaccine created by GlaxoSmithKline (Belgium). The vaccine is registered and allowed in our country. It does not contain DNA of oncogenic HPV strains and does not lead to the progression or relapse of the disease after vaccination.
How effective is the vaccine?
The high efficacy (98%) of the cervical cancer vaccine has been proven in numerous studies involving more than 18,000 women worldwide. For 8.4 years after vaccination, protection against precancerous lesions of the cervix remains. These data are recognized by experts from the European Union, USA and other countries.
Indications for vaccination
Vaccination is indicated to prevent 2nd and 3rd degree cervical intraepithelial neoplasia (CIN) and cervical cancer caused by human papillomavirus (HPV) in girls from 12 years old and women who have sexual life, or plan to start it.
Contraindications to vaccination
Contraindications to vaccination are:
- severe systemic diseases;
- thrombocytopenia and other coagulation disorders that can trigger bleeding at the injection site.
How is vaccination performed?
In the Bogoliuby Medical Center, vaccination is carried out subject to sanitary and epidemiological rules and norms, using only disposable, self-locking syringes, which guarantees the patient the accuracy of the dose and the possibility of one-time use.
The vaccine is administered intramuscularly in the upper third of the shoulder. Three doses of the vaccine are administered over a period of 6 months at prescribed intervals - to ensure maximum effectiveness.
